Skip to content
FederalSources soughtOpen Federal notice

Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics

National Institutes of Health› National Institutes of Health NIDA Bethesda, MD

Solicitation # 75N98027R00020Updated Nov 16, 2026Scored Nov 17, 2026

Responses due

Nov 30

Nov 30, 2026, 11:00 AM EST

Posted Nov 16Due Nov 30

Summary by RFP Detector

What this RFP is about

National Institutes of Health (National Institutes of Health NIDA), part of the Department of Health and Human Services, posted a sources sought notice titled “Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics” under solicitation number 75N98027R00020. It was posted on Nov 16, 2026. Responses are due Nov 30, 2026, 11:00 AM EST. It is classified under NAICS 325411 (Medicinal and Botanical Manufacturing) and product/service code AN11. No set-aside is listed. The place of performance is Bethesda, Maryland. The listed point of contact is Polina Klimenkova.

Key facts

Sector
Federal
Notice type
Sources sought
As posted: Sources Sought
PSC
AN11
Place of performance
Bethesda, MD
Value
Not stated
Solicitation #
75N98027R00020
Listing
Official federal notice

RFP Detector Score

Score breakdown

Every RFP starts at 50. Each factor adds or subtracts points compared with a typical RFP; unknown data counts as neutral.

Starts at 50

  • Value0.0unknown

    No value published, and there isn't enough award history to estimate one. Scored as neutral.

  • Competition & access−0.6estimated

    Full and open competition.

  • Issuer & market+0.2estimated

    8 other RFPs from National Institutes of Health on RFP Detector in the past 12 months; no award history found.

  • Time & stage+5.4measured

    Sources sought (market research, not a bid): 13 days to respond (due Nov 30, 2026, 11:00 AM EST).

  • Clarity & completeness+3.4estimated

    Documents not listed, named contact with email and phone, 456-word description.

  • Freshness+9.0measured

    Posted today.

50 + contributions = 67 (B, Strong)

Informational, not advice to bid or not bid. Score version 1.0.0, evaluated Nov 17, 2026.

Requirements & submission

Eligibility · Full and open competition

Full and open competition means the notice states no set-aside: any responsible business can respond, subject to the requirements in the notice.

Not stated in a form we could extract. See the official solicitation for requirements, evaluation criteria and submission steps.

From the official notice

Description

456 words

Title: Reagent Generation for Bioanalytical Method Development on Biologics Therapeutics This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement. This notice is issued to help determine the availability of qualified companies technically capable of meeting the Government requirement and to determine the method of acquisition. It is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. Responses will not be considered as proposals or quotes. No award will be made as a result of this notice. The Government will NOT be responsible for any costs incurred by the respondents to this notice. This notice is strictly for research and information purposes only. The Government is especially interested in determining (1) the availability of qualified small business sources; (2) whether they are small businesses; HUBZone small businesses; service-disabled, veteran-owned small businesses; 8(a) small businesses; veteran-owned small businesses; woman-owned small businesses; or small disadvantaged businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition (5) commercial product and services availability. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. Background: The Therapeutic Development Branch (TDB) within the Division of Preclinical Innovation (DPI) at National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH) conducts translational research in the area of human therapeutics development by moving small molecule and biologic drug candidates forward in the drug development pipeline. Upon reaching predetermined milestones, TDB hands off clinical candidates to external partners to bring these novel therapies to patients. In addition to developing new candidate drugs, TDB seeks to advance the entire field of drug discovery and development by encouraging scientific and technological innovations aimed at improving success rates in the crucial preclinical stage of drug development. The TDB model is to operate as a comprehensive small molecule and biologics drug development organization, moving therapeutic candidates through each phase of the preclinical development process until an Investigational New Drug (IND) application is filed with the US Food and Drug Administration (FDA). TDB conducts drug development as collaborations, with therapeutic candidates originating from academia, industry, non- profit foundations, or internally from NCATS and other NIH Institutes and Centers. TDB’s operational strategy is to combine the capabilities of in-house staff and collaborative partners with complementary support from contract research organizations (CROs). Each development program operates in a multi-disciplinary matrix team environment, with NCATS responsible for the overall planning and execution. Please see the attachment for more details.

Documents

No documents are listed for this notice.

Contacts

Points of contact as published on the notice.

Timeline & history

  1. Sources Sought posted

  2. Responses dueNext · in 13 days

  3. Archive date on the official notice

Similar open RFPs

Same NAICS group or Healthcare & Medical, nearby first, ranked by score.

Poor

Reagents and consumables for Roche immunostainers

National Institutes of Health · Bethesda, MD

FederalCombined synopsisHealthcare & Medical
Posted Oct 30Due Nov 18, 2026, 8:00 AM EST (in 23 h)Federal notice
Strong

Cmcs - Combined Synopsis - Solicitation - Fci Cumberland

Federal Prison System / Bureau of Prisons · Cumberland, MD

FederalRFPHealthcare & Medical
Posted Mar 9Due Feb 4, 2027, 2:00 PM EST (in 79 days)Federal notice
Strong

Baxter/Hill-Rom Helux Pro Surgical Light System

National Institutes of Health · Brooklyn, MD

FederalSources soughtSmall business set-asideHealthcare & Medical+1
Posted Nov 16Due Dec 8, 2026, 2:00 PM EST (in 21 days)Federal notice
Fair

Storage and monitoring of ManNac for FDA regulations

National Institutes of Health · Bethesda, MD

FederalPresolicitationEngineering & Architecture
Posted Nov 16Due Nov 26, 2026, 9:00 AM EST (in 9 days)Federal notice

RFP Detector Scores are informational.How we score →

More from National Institutes of Health

68 open RFPs from this issuer and its offices.

Limited

NCSS - Onboarding NHLBI to NEI OpenSpecimen

National Institutes of Health

FederalCombined synopsisIT & Software
Posted Nov 3Due Nov 17, 2026, 9:00 AM EST (in < 1 h)Federal notice
Poor

Reagents and consumables for Roche immunostainers

National Institutes of Health · Bethesda, MD

FederalCombined synopsisHealthcare & Medical
Posted Oct 30Due Nov 18, 2026, 8:00 AM EST (in 23 h)Federal notice
Limited

BioRad QX700 E Droplet Digital PCR System

National Institutes of Health · Bethesda, MD

FederalCombined synopsisSupplies, Equipment & Furniture
Posted Nov 4Due Nov 18, 2026, 9:00 AM EST (in 24 h)Federal notice

RFP Detector Scores are informational.How we score →

About this notice

Official federal notice. Updated Nov 16, 2026.

Official solicitation:Sign in free to open the official solicitation

RFP Detector is an independent service and is not affiliated with any government agency. Scores are informational.

RFP Detector is not affiliated with the organization that issued this RFP. Always rely on the official notice and confirm every date and requirement with the issuer.